公告 [Amend] General statement of acquisition of beneficial ownership

发表于 2024-04-05 23:48   382次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-04-05 23:35   388次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-04-05 23:35   387次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-04-05 23:35   371次浏览

公告 Notification filed by national security exchange to report the removal from lis

发表于 2024-04-05 23:35   392次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-04-05 23:35   385次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2024-04-05 23:34   382次浏览

公告 Post-Effective amendments for registration statement

发表于 2024-04-05 22:55   376次浏览

公告 Current report, items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, and 9.01

发表于 2024-04-05 22:40   395次浏览

公告 [Amend] Going private transaction by certain issuers

发表于 2024-04-05 22:04   403次浏览

公告 [Amend] Going private transaction by certain issuers

发表于 2024-04-05 21:54   384次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2024-04-05 21:51   392次浏览

公告 [Amend] Annual report [Section 13 and 15(d), not S-K Item 405]

发表于 2024-04-05 05:48   388次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2024-03-30 05:45   366次浏览

公告 NGM Biopharmaceuticals Inc|Contract Adjustment

发表于 2024-03-25 00:00   92次浏览

公告 [Amend] Going private transaction by certain issuers

发表于 2024-03-23 05:55   350次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2024-03-23 05:31   371次浏览

公告 [Amend] Going private transaction by certain issuers

发表于 2024-03-23 05:30   343次浏览

公告 Current report, items 2.02 and 9.01

发表于 2024-03-12 04:35   361次浏览

公告 Annual report [Section 13 and 15(d), not S-K Item 405]

发表于 2024-03-12 04:32   362次浏览